Samiya Adem, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2233 University Ave W, Saint Paul, MN 55114 Phone: 205-199-4767 |
Georgia Roxanne Ward, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 345 Smith Ave N, Saint Paul, MN 55102 Phone: 651-220-6944 |
Kaitlin Rose Mart, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1440 University Ave W, Saint Paul, MN 55104 Phone: 651-646-8858 Fax: 651-646-9699 |
Sara Saini Maki, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 153 Cesar Chavez St, Saint Paul, MN 55107 Phone: 651-602-7500 |
Alicia Ann Beseres, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: Children's Minnesota Outpatient Pharmacy, 345 Smith Ave N, Saint Paul, MN 55102 Phone: 651-220-6944 Fax: 651-220-6966 |
Aaron Drake Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2076 Saint Anthony Ave, Saint Paul, MN 55104 Phone: 651-789-5028 |
Dr. Jeffrey David Wigfield, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1031 Mendota Heights Rd, Saint Paul, MN 55120 Phone: 612-306-2721 |
Tara Jean Tindall, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1300 University Ave W, Saint Paul, MN 55104 Phone: 651-646-8002 |
Michele Marie Marshall, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 345 Smith Ave N, Saint Paul, MN 55102 Phone: 651-220-6962 |
Natalie Pavek, PHARMD Pharmacist - Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist Medicare: Not Enrolled in Medicare Practice Location: 345 Smith Ave N, Saint Paul, MN 55102 Phone: 651-220-6962 |
Mikal Rutten, PHARMD Pharmacist - Pharmacotherapy Medicare: Not Enrolled in Medicare Practice Location: 640 Jackson St, Mail Stop 12101b, Saint Paul, MN 55101 Phone: 651-254-1550 |
Robin Peterson, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2197 Old Hudson Rd, Saint Paul, MN 55119 Phone: 651-501-4934 Fax: 651-501-7453 |
Amanda Moltzan, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2099 Ford Pkwy, Saint Paul, MN 55116 Phone: 651-414-3882 |
Julia Marie Houston, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1585 Randolph Ave, Saint Paul, MN 55105 Phone: 651-698-6502 |
Jeena Lee, PHARM.D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1300 University Ave W, Saint Paul, MN 55104 Phone: 651-646-8002 Fax: 651-255-4681 |
Mary Jo Zurbey, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1744 Suburban Ave, Saint Paul, MN 55106 Phone: 651-778-0105 |
Sharon Rose Kahnke, PHARM-D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 240 Snelling Ave S, Saint Paul, MN 55105 Phone: 651-698-8859 |
Kristyn Murphy Hamm, PHARMD, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 360 Sherman St Ste 100, Saint Paul, MN 55102 Phone: 651-468-0604 Fax: 651-468-0606 |
Rebecca Montanari Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2080 Ford Pkwy, Saint Paul, MN 55116 Phone: 651-605-3634 |
Mark A Schoolman, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1075 Highway 96 E, Saint Paul, MN 55127 Phone: 651-426-9225 Fax: 651-429-4041 |
News Archive
A new study by Vanderbilt University Medical Center researchers of more the 400,000 Medicare patients taking medications for insomnia found that the risk of death is increased when either benzodiazepines or "z-drugs" are taken with opioids.
Tetraphase Pharmaceuticals, Inc., today presented encouraging preclinical data for its lead drug candidate, TP-434, which showed the potent antibacterial activity of TP-434 against a very broad spectrum of susceptible and multidrug-resistant pathogens.
A team of experts from the University of California Firearm Violence Research Center says the purchase and interpersonal use of firearms in the United States has increased during the coronavirus disease 2019 (COVID-19) pandemic.
Bayer HealthCare Pharmaceuticals Inc. and Onyx Pharmaceuticals, Inc., an Amgen subsidiary (Nasdaq: AMGN), today announced that a Phase 3 trial evaluating the investigational use of NEXAVAR® (sorafenib) tablets as an adjuvant treatment for patients with hepatocellular carcinoma (HCC), or liver cancer, who had no detectable disease after surgical resection or local ablation, did not meet its primary endpoint of improving recurrence-free survival.
A new study published in Open Access journal PLOS Biology by the Global Biological Standards Institute (GBSI) and two leading economists estimates that, in the U.S. alone, approximately $28 billion per year is spent on preclinical research that is not reproducible.
› Verified 2 days ago